Patents by Inventor Cynthia Burnell

Cynthia Burnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION
    Publication number: 20220211825
    Abstract: The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: Martin Babcock, Cynthia Burnell, Vikram Kalthod, Joerg Breitenbach, Frithjof Sczesny, Frauke-Regina Rueffer, George Shlieout
  • Enzyme compositions with reduced viral and microbial contamination
    Patent number: 11278603
    Abstract: The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: March 22, 2022
    Assignee: AbbVie Inc.
    Inventors: Martin Babcock, Cynthia Burnell, Vikram Kalthod, Joerg Breitenbach, Frithjof Sczesny, Frauke-Regina Rueffer, George Shlieout
  • ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION
    Publication number: 20190201502
    Abstract: The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 4, 2019
    Inventors: Martin Babcock, Cynthia Burnell, Vikram Kalthod, Joerg Breitenbach, George Shlieout, Frithjof Sczesny, Frauke-Regina Rueffer
  • ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION
    Publication number: 20180036393
    Abstract: The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
    Type: Application
    Filed: September 27, 2017
    Publication date: February 8, 2018
    Inventors: Martin Babcock, Cynthia Burnell, Daniel Crandall, John Dete, Mark Hess, Shannon Hertzler, Vikram Kalthod, William Riordan, Houston Sanders
  • ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION
    Publication number: 20170274055
    Abstract: The present invention pertains to an enzyme preparation obtained from e-beam irradiated animal tissue, such as porcine pancreas. The present invention also pertains to methods for making such enzyme preparations, pharmaceutical compositions comprising such enzymes preparations, and methods for using such pharmaceutical compositions and enzyme preparations.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 28, 2017
    Inventors: Martin Babcock, Cynthia Burnell, Daniel Crandall, John Dete, Mark Hess, Shannon Hertzler, Vikram Kalthod, William Riordan, Houston Sanders
  • Macrocyclic 13-membered ring derivatives of erythromycins A and B
    Patent number: 5712253
    Abstract: Novel macrocyclic 13-membered ring-contracted compounds derived from erythromycins A and B having the Formula (I) ##STR1## and pharmaceutically acceptable salts thereof, wherein R, R.sup.1, R.sup.2, R.sup.3 and X are specifically defined, having use in treating gastrointestinal disorders associated with hypermotilinemia, pharmaceutical compositions thereof, a method of treating gastrointestinal disorders associated with hypermotilinemia with said pharmaceutical compositions, and processes for the preparation thereof.
    Type: Grant
    Filed: June 18, 1996
    Date of Patent: January 27, 1998
    Assignee: Abbott Laboratories
    Inventors: Paul A. Lartey, Cynthia Burnell Curty, Ramin Faghih, Hugh Nerby Nellans, Albert Christian Petersen